Skip to content
FDA.report
Public FDA data
NDC
RxNorm
DailyMed
Applications
GUDID
PMA
PMN
MAUDE
Recalls
Search FDA.report
Search
Home
DailyMed
class
ea0c9867-3299-46c9-995e-322af53f0519
TAFLUPROST Pharmacologic Class Indexing
Class set ID
ea0c9867-3299-46c9-995e-322af53f0519
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class
Mapped DailyMed Labels
#
Label, Manufacturer, Effective table
Label
Manufacturer
Effective
SPL version
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Thea Pharma Inc.
20260423
7
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Sandoz Inc
20260325
12
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution 0.0015%, for topical ophthalmic use Initial U.S. Approval: 2012
Micro Labs Limited
20260306
6
These highlights do not include all the information needed to use TAFLUPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TAFLUPROST OPHTHALMIC SOLUTION. TAFLUPROST ophthalmic solution Initial U.S. Approval: 2012
Ingenus Pharmaceuticals, LLC | Kaysersberg Pharmaceuticals
20241204
7
These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012
Akorn
20221004
10
These highlights do not include all the information needed to use Tafluprost Ophthalmic Solution 0.0015% safely and effectively. See full prescribing information for Tafluprost Ophthalmic Solution. Tafluprost Ophthalmic Solution 0.0015% Initial U.S. Approval: 2012
Prasco Laboratories
20220601
1